FindTrial
Sign In

Comparison of two airway devices that inserted in upper airway in adult patients undergoing surgeries under general anaesthesia.

Comparison of fibreoptic glottic view attained post insertion of Ambu Auragain and LMA Protector in adult patients undergoing surgeries under General Anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048948
Enrollment
88
Registered
2023-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: N29- Other disorders of kidney and ureter in diseases classified elsewhere Health Condition 3: K638- Other specified diseases of intestine

Interventions

Intervention1: LMA PROTECTOR: The LMA Protector is 2nd generation supraglottic airway device which provides functional separation of the respiratory and digestive tracts. There are two ports (male, fe

Sponsors

Command Hospital (Eastern Command)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I to III Age > 18Y Surgery under GA with anticipated duration Thyromental distance of >6.5cm

Exclusion criteria

Exclusion criteria: Reduced mouth opening ( Recent h/o URTI, sore throat BMI > 40 Non fasted state

Design outcomes

Primary

MeasureTime frame
Fibreoptic assessment of glottic view by BRIMACOMBE SCORE & POGO SCORETimepoint: Two hours—

Secondary

MeasureTime frame
1.Oropharyngeal leak pressure 2.Time for successful supraglottic device insertion 3.Pharyngolaryngeal complications(Sore throat, Dysphagia at 1, 2, 12 and 24h post operatively) Timepoint: Twenty four hours—

Countries

India

Contacts

Public ContactMaj Dr Mani Kandan A

Command Hospital (Eastern Command)

manikndanmmc2009.mk@gmail.com9626093555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026